Literature DB >> 7840227

Glucocorticosteroids increase beta 2-adrenergic receptor transcription in human lung.

J C Mak1, M Nishikawa, P J Barnes.   

Abstract

beta 2-Adrenergic receptors (beta 2R) are widely distributed and mediate a wide range of cellular responses in lung. Because glucocorticosteroids increase expression of beta 2R in cell lines, we have investigated the effects of glucocorticoids on the beta 2R mRNA level and the number of beta 2R in human peripheral lung in vitro. Incubation of lung tissues with dexamethasone (Dex) elevated both beta 2R mRNA level (as measured by Northern blot analysis) and beta 2R number (as measured by [125I]iodocyanopindolol binding). The increased accumulation of beta 2R mRNA could be detected at 15 min (1.27 +/- 0.1-fold) and the maximal accumulation occurred at 2 h (2.73 +/- 0.5-fold). The Dex-induced increase in beta 2R mRNA returned to the control level by 17 h. The increase in beta 2R number (1.58 +/- 0.2-fold) was slower, reaching a maximum between 17 and 24 h. Dex increased beta 2R mRNA in a time- and concentration-dependent manner that was abolished by the steroid receptor antagonist mifepristone (RU-38486 or RU-486). The stability of beta 2R mRNA was unchanged by Dex, and a nuclear run-on assay revealed that Dex approximately doubled the transcriptional rate of the beta 2R gene. These observations suggest that glucocorticoids act on steroid receptors to increase beta 2R expression by increasing the rate of beta 2R gene transcription.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7840227     DOI: 10.1152/ajplung.1995.268.1.L41

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  34 in total

Review 1.  Pharmacologic management of the hospitalized pediatric asthma patient.

Authors:  K A Hardin; H J Kallas; R J McDonald
Journal:  Clin Rev Allergy Immunol       Date:  2001-06       Impact factor: 8.667

Review 2.  Pharmacogenetics of asthma.

Authors:  A Fenech; Ian P Hall
Journal:  Br J Clin Pharmacol       Date:  2002-01       Impact factor: 4.335

Review 3.  Antagonism of long-acting beta2-adrenoceptor agonism.

Authors:  Brian J Lipworth
Journal:  Br J Clin Pharmacol       Date:  2002-09       Impact factor: 4.335

Review 4.  Interactions between corticosteroids and beta2-agonists.

Authors:  Robert J Hancox
Journal:  Clin Rev Allergy Immunol       Date:  2006 Oct-Dec       Impact factor: 8.667

Review 5.  A Holy Grail of asthma management: toward understanding how long-acting beta(2)-adrenoceptor agonists enhance the clinical efficacy of inhaled corticosteroids.

Authors:  M A Giembycz; M Kaur; R Leigh; R Newton
Journal:  Br J Pharmacol       Date:  2007-12-10       Impact factor: 8.739

6.  Postnatal changes in beta-adrenoceptors in the lung and the effect of hypoxia induced pulmonary hypertension of the newborn.

Authors:  Alison A Hislop; Judith C W Mak; David Kelly; Jayne A Reader; Peter J Barnes; Sheila G Haworth
Journal:  Br J Pharmacol       Date:  2002-03       Impact factor: 8.739

7.  Inhaled corticosteroid treatment modulates ZNF432 gene variant's effect on bronchodilator response in asthmatics.

Authors:  Ann Chen Wu; Blanca E Himes; Jessica Lasky-Su; Augusto Litonjua; Stephen P Peters; John Lima; Michiaki Kubo; Mayumi Tamari; Yusuke Nakamura; Weiliang Qiu; Scott T Weiss; Kelan Tantisira
Journal:  J Allergy Clin Immunol       Date:  2013-11-23       Impact factor: 10.793

8.  Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo.

Authors:  J C Mak; M Nishikawa; H Shirasaki; K Miyayasu; P J Barnes
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

Review 9.  Budesonide/formoterol combination in COPD: a US perspective.

Authors:  Amir Sharafkhaneh; Amarbir S Mattewal; Vinu M Abraham; Goutham Dronavalli; Nicola A Hanania
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-10-05

10.  Steroids augment relengthening of contracted airway smooth muscle: potential additional mechanism of benefit in asthma.

Authors:  O J Lakser; M L Dowell; F L Hoyte; B Chen; T L Lavoie; C Ferreira; L H Pinto; N O Dulin; P Kogut; J Churchill; R W Mitchell; J Solway
Journal:  Eur Respir J       Date:  2008-09-03       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.